02 May 2003
Effects of 5-AIQ on the multiple organ failure associated to thermal injury in the rat
M. Caneira, B. Sepodes, R. Pinto, H. Mota-Filipe, C. ThiemermannMed Sci Monit 2003; 9(1): 7-0 :: ID: 14992
Abstract
Thermal injury initiates a systemic inflammatory response resulting (among others) in the formation of reactive oxygen species (ROS), which may contribute to DNA injury [1]. One possible way of ROS-induced injury involves the excessive activation of poly-(ADP-ribose) polymerase (PARP). The aim of this study was to investigate the effect of the water-soluble inhibitor of PARP, 5-aminoisoquinoline (5-AIQ) on the circulatory and multiple organ failure in rats with thermal injury.Male Wistar rats (300–350 g) were divided in three groups: Control, burn (B) and burn-treated (BT) with 5-AIQ (3 mg/kg i.p., 1 minute after burn and every 2 h). The rats in groups B and BT received a 60% total body surface area scald burn (70°C during 30 seconds) under general anaesthesia, which was maintained until the end of the experiment. Rats were sacrificed 6 h after the injury and blood samples were collected immediately before sacrifice. Determination of serum biochemical markers of liver injury (AST and ALT) and renal dysfunction (urea and creatinine) was done. Mean arterial blood pressure (MAP) was determined every 30 min. Burned animals shown a significant and progressive decrease in MAP towards the end of 6 h experiment, and this hypotension was unaffected by 5-AIQ. Burn induced a significant increase on the serum levels of AST, ALT, urea and creatinine. This multiple organ injury/dysfunction was significantly attenuated by 5-AIQ. Thus, administration of 5-AIQ immediately after a 60% scald burn attenuated the dysfunction and liver injury, but not the circulatory failure associated with severe burn injury.References: 1.Martin D, Lewington A, Hammerman M, Padanilam B: Inhibition of poly (ADP-ribose) polymerase attenuates ischemic renal injury in rats. Am J Physiol Regulatiry Integrative Comp Physiol, 2000; 279: 1834-40
Keywords: thermal injury, Burn, PARP, 5-aminoisoquinoline, Rat
476 0
Editorial
01 May 2023 : Editorial
Editorial: Twenty Years On from Sequencing the Human Genome, Personalized/Precision Oncology Prepares to Meet the Challenges of Checkpoint Inhibitor TherapyDOI: 10.12659/MSM.940911
Med Sci Monit 2023; 29:e940911
In Press
31 May 2023 : Review article
Prevalence, Diagnosis, and Management of Eclampsia and the Need for Improved Maternal Care: A ReviewMed Sci Monit In Press; DOI: 10.12659/MSM.939919
30 May 2023 : Clinical Research
A Case-Control Study of Cognitive Function in Patients with End-Stage Renal Disease Before and After Hemodi...Med Sci Monit In Press; DOI: 10.12659/MSM.940409
30 May 2023 : Review article
A Review of the Role of the Zebrafish (Danio reiro) in Preclinical and Clinical Models of Biomarker Identif...Med Sci Monit In Press; DOI: 10.12659/MSM.940550
30 May 2023 : Database Analysis
The COVID-19 Crisis and the Incidence of Alcohol-Related Deaths in PolandMed Sci Monit In Press; DOI: 10.12659/MSM.940904
Most Viewed Current Articles
13 Nov 2021 : Clinical Research
Acceptance of COVID-19 Vaccination and Its Associated Factors Among Cancer Patients Attending the Oncology ...DOI :10.12659/MSM.932788
Med Sci Monit 2021; 27:e932788
30 Dec 2021 : Clinical Research
Retrospective Study of Outcomes and Hospitalization Rates of Patients in Italy with a Confirmed Diagnosis o...DOI :10.12659/MSM.935379
Med Sci Monit 2021; 27:e935379
08 Mar 2022 : Review article
A Review of the Potential Roles of Antioxidant and Anti-Inflammatory Pharmacological Approaches for the Man...DOI :10.12659/MSM.936292
Med Sci Monit 2022; 28:e936292
01 Jan 2022 : Editorial
Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...DOI :10.12659/MSM.935952
Med Sci Monit 2022; 28:e935952